HOME >> BIOLOGY >> NEWS
Uncertainty in clinical tests raises health care costs

Small measurement uncertainties in clinical laboratory tests can add large amounts to health care costs, according to a newly released study commissioned by the National Institute of Standards and Technology (NIST).

The study,* conducted by RTI International (Research Triangle Park, N.C.) and the Mayo Clinic (Rochester, Minn.), estimates that calibration errors in measurements of calcium levels in blood may add between $60 million and $199 million to U.S. health care costs annually. High calcium levels can be a symptom of diseases such as cancer and thyroid disorders.

Accurate measurements are critical because calcium levels in healthy people fall within a narrow range, between 8.9 to 10.1 milligrams (mg) per deciliter (dL). Through interviews with laboratory managers and equipment manufacturers, the researchers estimated that results for up to 15 percent of calcium laboratory tests contain calibration errors of between 0.1 and 0.5 mg per dL. This means that some results that fall in the center of the "normal" range, say 9.7 mg/dL, may in fact be for patient samples with elevated calcium, defined as 10.2 mg/dL and above. At the same time, patients with measured values above the threshold, but who actually have normal calcium levels, may receive unnecessary follow-up procedures such as hormone measurements and chest X-rays.

The study analyzed data for more than 89,000 patients receiving serum calcium tests at the Mayo Clinic from 1998 to 1999. It found that calibration errors added between $8 and $89 per patient to the health care costs of approximately 3.55 million patients.

Major sources of calibration error include differences in analysis methods used by different laboratory instruments, lot-to-lot variations in calibration materials, and lack of "traceability" between secondary reference materials and primary standards such as Standard Reference Materials produced by NIST.


'"/>

Contact: Laura Ost
laura.ost@nist.gov
301-975-4034
National Institute of Standards and Technology (NIST)
7-May-2004


Page: 1

Related biology news :

1. Preclinical safety study shows adipose-derived stem cells improve heart function after heart attack
2. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
3. Innovative ceramic-on-metal hip replacements to undergo clinical trials
4. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find
5. Warren Pharmaceuticals publishes results of preclinical evaluation
6. Creation of the UK Clinical Research Collaboration will boost clinical trials in UK
7. Scientists characterize new breast tumor subtypes with poor clinical outcomes
8. Vanderbilts John Oates wins clinical research award
9. Germany starts clinical development of a new tuberculosis vaccine
10. Heart and lung transplantation clinical trial results to be announced at ISHLT meeting
11. Genetic profile, not clinical appearance, to determine tumor treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/6/2017)... 6, 2017 Forecasts by Product ... Readers, by End-Use (Transportation & Logistics, Government & Public ... & Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business ... Are you looking for a definitive report on ... ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/28/2017)... , March 28, 2017 ... Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video ... and Region - Global Forecast to 2022", published by ... in 2016 and is projected to reach USD 75.64 ... 2017 and 2022. The base year considered for the ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... Iowa (PRWEB) , ... October 12, 2017 , ... ... based in Vilnius, Lithuania, announced today that they have entered into a multiyear ... is to provide CRISPR researchers with additional tools for gene editing across all ...
(Date:10/11/2017)... ... October 11, 2017 , ... At ... Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research scientist ... has been selected for membership in ARCS Alumni Hall of Fame . ...
(Date:10/11/2017)... BioMarketing, a leading provider of patient support solutions, has announced ... network, which will launch this week. The VMS CNEs will ... to enhance the patient care experience by delivering peer-to-peer education ... professionals to help women who have been diagnosed and are ... ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... San Diego-based ... of its corporate rebranding initiative announced today. The bold new look is part ... as the company moves into a significant growth period. , It will also expand ...
Breaking Biology Technology:
Cached News: